Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan Aim: We compared the effects of nefecon, an oral targeted-release budesonide formulation, and sparsentan, an oral, dual endothelin-angiotensin receptor antagonist, on estimated glomerular filtration r...

📢New article alert

New research: “Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan”.

🔗 becarispublishing.com/doi/10.57264...

#OpenAccess #JCER #KidneyDisease #RWE #MAIC #HEOR #ComparativeEffectiveness

Matching-adjusted indirect comparisons of diroximel fumarate, ocrelizumab and interferon beta-1a for relapsing multiple sclerosis Aim: This study compares the efficacy of diroximel fumarate (DRF) with ocrelizumab (OCR) and interferon beta-1a (IFNβ-1a) for treating relapsing multiple sclerosis (MS) through matching-adjusted indir...

📢 New research in JCER: “Matching-adjusted indirect comparisons of diroximel fumarate, ocrelizumab and interferon beta-1a for relapsing multiple sclerosis”.

🔗 becarispublishing.com/doi/10.57264...

#OpenAccess #JCER #MultipleSclerosis #MAIC #RWE #ComparativeEffectiveness

Evaluation of the efficacy and cost-effectiveness of safinamide versus rasagiline: a systematic review Aim: This systematic review aimed to evaluate the comparative efficacy, safety and cost-effectiveness of safinamide (50/100 mg) versus rasagiline (1 mg) in managing Parkinson’s disease (PD)....

📢 New in JCER: "Evaluation of the efficacy and cost-effectiveness of safinamide versus rasagiline: a systematic review".

Read more here: 🔗 becarispublishing.com/doi/10.57264...

#OpenAccess #JCER #ParkinsonsDisease #ComparativeEffectiveness #SystematicReview